Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 1962

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 16
Chunk 1962
---
,092  
     3,526,926 
  
    Payroll and related expenses 
     3,874,092  
     5,206,451 
  
    General and administrative 
     3,243,181  
     3,903,191 
  
    Total operating expenses 
     9,341,365  
     12,636,568 

    OPERATING LOSS 
     (9,341,365) 
     (12,636,568)

    OTHER EXPENSE (INCOME), NET 

    Interest income 
     (298,122) 
     (447,356)
  
    Other income 
     (324,450) 
     – 
  
    Interest expense 
     10,109  
     – 
  
    Other expense 
     4,659,188  
     18,962 
  
    Total other expense (income), net 
     4,046,725  
     (428,394)

    NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS 
     (13,388,089) 
     (12,208,174)

    Basic and diluted net loss per share attributable to common stockholders 
    $(8.58) 
    $(38.87)

    Weighted average number of common shares outstanding - basic and diluted 
     1,560,839  
     314,097 

    NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS 
     (13,388,089) 
     (12,208,174)

    OTHER COMPREHENSIVE LOSS 
     (10,193) 
     (799)

    COMPREHENSIVE LOSS 
    $(13,398,282) 
    $(12,208,973)

See accompanying notes to the consolidated financial
statements.

 F-6 

AETHLON MEDICAL, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF EQUITY

FOR THE YEARS ENDED MARCH 31, 2025 AND 2024

    COMMON STOCK  
    ADDITIONAL PAID IN  
    ACCUMULATED  
    ACCUMULATED COMPREHENSIVE  
    TOTAL 

    SHARES  
    AMOUNT  
    CAPITAL  
    DEFICIT  
    LOSS  
    EQUITY 
  
    BALANCE